$GKOS
GLAUKOS Corp

2020 Q4 Form 10-Q Financial Statement

#000155837020012925 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $73.23M $64.83M $58.51M
YoY Change 11.22% 10.81% 33.25%
Cost Of Revenue $19.59M $17.93M $7.703M
YoY Change 23.18% 132.79% 28.15%
Gross Profit $53.64M $46.90M $50.81M
YoY Change 7.41% -7.69% 34.06%
Gross Profit Margin 73.25% 72.34% 86.83%
Selling, General & Admin $43.79M $38.95M $44.44M
YoY Change -26.54% -12.37% 40.5%
% of Gross Profit 81.63% 83.04% 87.48%
Research & Development $21.24M $20.30M $17.28M
YoY Change 6.06% 17.51% 30.87%
% of Gross Profit 39.6% 43.29% 34.01%
Depreciation & Amortization $7.400M $7.340M $940.0K
YoY Change 103.3% 680.85% -44.71%
% of Gross Profit 13.79% 15.65% 1.85%
Operating Expenses $65.04M $59.25M $63.22M
YoY Change -18.34% -6.28% 41.01%
Operating Profit -$11.39M -$12.35M -$12.42M
YoY Change -61.64% -0.51% 78.97%
Interest Expense -$5.130M -$5.140M -$850.0K
YoY Change -984.48% 504.71% -246.55%
% of Operating Profit
Other Income/Expense, Net -$2.499M -$4.285M -$904.0K
YoY Change -671.85% 374.0% -356.09%
Pretax Income -$13.89M -$16.64M -$13.32M
YoY Change -52.53% 24.91% 102.29%
Income Tax -$3.243M -$889.0K $187.0K
% Of Pretax Income
Net Earnings -$10.65M -$15.75M -$13.51M
YoY Change -129.11% 16.6% 103.99%
Net Earnings / Revenue -14.54% -24.29% -23.08%
Basic Earnings Per Share -$0.24 -$0.35 -$0.37
Diluted Earnings Per Share -$0.24 -$0.35 -$0.37
COMMON SHARES
Basic Shares Outstanding 44.96M 44.71M 36.83M
Diluted Shares Outstanding 44.71M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $404.4M $388.4M $152.9M
YoY Change 132.41% 154.02% 10.96%
Cash & Equivalents $96.60M $80.99M $39.53M
Short-Term Investments $307.8M $307.4M $113.4M
Other Short-Term Assets $13.20M $13.20M $19.20M
YoY Change 67.09% -31.25% 357.14%
Inventory $15.81M $19.89M $12.80M
Prepaid Expenses
Receivables $36.06M $32.89M $24.35M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $469.4M $454.4M $209.3M
YoY Change 78.58% 117.14% 19.46%
LONG-TERM ASSETS
Property, Plant & Equipment $24.01M $23.41M $20.04M
YoY Change 8.85% 16.82% 62.91%
Goodwill $66.13M $66.13M
YoY Change 0.0%
Intangibles $357.7M $363.9M
YoY Change -6.51%
Long-Term Investments
YoY Change
Other Assets $16.80M $15.90M $12.40M
YoY Change 12.0% 28.23% 376.92%
Total Long-Term Assets $536.1M $540.1M $98.15M
YoY Change -3.5% 450.26% 541.49%
TOTAL ASSETS
Total Short-Term Assets $469.4M $454.4M $209.3M
Total Long-Term Assets $536.1M $540.1M $98.15M
Total Assets $1.006B $994.5M $307.4M
YoY Change 22.86% 223.49% 61.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.371M $6.774M $3.501M
YoY Change -24.39% 93.49% -37.48%
Accrued Expenses $45.33M $39.92M $29.60M
YoY Change -12.69% 34.85% 54.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K
YoY Change
Total Short-Term Liabilities $49.70M $46.69M $33.10M
YoY Change -13.86% 41.05% 33.48%
LONG-TERM LIABILITIES
Long-Term Debt $250.1M $247.4M $68.90M
YoY Change 328.25% 259.07%
Other Long-Term Liabilities $7.029M $5.982M $3.960M
YoY Change 36.06% 51.06% 72.17%
Total Long-Term Liabilities $7.029M $5.982M $3.960M
YoY Change 36.06% 51.06% 72.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $49.70M $46.69M $33.10M
Total Long-Term Liabilities $7.029M $5.982M $3.960M
Total Liabilities $338.1M $333.0M $117.3M
YoY Change 132.93% 183.8% 332.92%
SHAREHOLDERS EQUITY
Retained Earnings -$310.1M -$299.4M -$226.3M
YoY Change 63.44% 32.31%
Common Stock $976.6M $959.2M $414.7M
YoY Change 13.33% 131.31%
Preferred Stock
YoY Change
Treasury Stock (at cost) $132.0K $132.0K $132.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares $28.00K $28.00K $28.00K
Shareholders Equity $667.4M $661.6M $190.1M
YoY Change
Total Liabilities & Shareholders Equity $1.006B $994.5M $307.4M
YoY Change 22.86% 223.49% 61.38%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$10.65M -$15.75M -$13.51M
YoY Change -129.11% 16.6% 103.99%
Depreciation, Depletion And Amortization $7.400M $7.340M $940.0K
YoY Change 103.3% 680.85% -44.71%
Cash From Operating Activities $10.60M -$9.570M -$2.990M
YoY Change -352.98% 220.07% -168.42%
INVESTING ACTIVITIES
Capital Expenditures -$2.150M -$1.280M -$1.010M
YoY Change 80.67% 26.73% 40.28%
Acquisitions
YoY Change
Other Investing Activities -$1.320M -$180.3M -$3.070M
YoY Change -102.59% 5772.31% -41.07%
Cash From Investing Activities -$3.460M -$181.6M -$4.080M
YoY Change -106.95% 4350.0% -31.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.660M 5.820M 6.660M
YoY Change -139.29% -12.61% -52.16%
NET CHANGE
Cash From Operating Activities 10.60M -9.570M -2.990M
Cash From Investing Activities -3.460M -181.6M -4.080M
Cash From Financing Activities 8.660M 5.820M 6.660M
Net Change In Cash 15.80M -185.3M -410.0K
YoY Change -33.02% 45097.56% -103.32%
FREE CASH FLOW
Cash From Operating Activities $10.60M -$9.570M -$2.990M
Capital Expenditures -$2.150M -$1.280M -$1.010M
Free Cash Flow $12.75M -$8.290M -$1.980M
YoY Change -525.0% 318.69% -138.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Registrant Name
EntityRegistrantName
GLAUKOS Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001192448
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37463
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0945406
dei Entity Address Address Line1
EntityAddressAddressLine1
229 Avenida Fabricante
dei Entity Address City Or Town
EntityAddressCityOrTown
San Clemente
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92672
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
367-9600
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
GKOS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62430000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
307441000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
111553000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44961417
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80994000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32885000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38417000
CY2020Q3 us-gaap Inventory Net
InventoryNet
19890000
CY2019Q4 us-gaap Inventory Net
InventoryNet
42578000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13235000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7900000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
454445000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
262878000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9326000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9326000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23408000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22056000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18760000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15704000
CY2020Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
51975000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
54048000
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
363921000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
382605000
CY2020Q3 us-gaap Goodwill
Goodwill
66134000
CY2019Q4 us-gaap Goodwill
Goodwill
66134000
CY2020Q3 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
6545000
CY2019Q4 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
5649000
CY2020Q3 us-gaap Assets
Assets
994514000
CY2019Q4 us-gaap Assets
Assets
818400000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6774000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5781000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39919000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
51919000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
46693000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
57700000
CY2020Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
186676000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18734000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14195000
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
60702000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
58435000
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
14164000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9632000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5982000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5166000
CY2020Q3 us-gaap Liabilities
Liabilities
332951000
CY2019Q4 us-gaap Liabilities
Liabilities
145128000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44855000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43530000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44827000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43502000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
45000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
44000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
959186000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
861740000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1874000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1330000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-299410000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189710000
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
661563000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
673272000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
994514000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
818400000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64831000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58509000
us-gaap Interest And Other Income
InterestAndOtherIncome
2368000
CY2020Q3 gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-5732000
CY2019Q3 gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-1028000
gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-8485000
gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-2041000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151725000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
171135000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17932000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7703000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
72129000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22684000
CY2020Q3 us-gaap Gross Profit
GrossProfit
46899000
CY2019Q3 us-gaap Gross Profit
GrossProfit
50806000
us-gaap Gross Profit
GrossProfit
79596000
us-gaap Gross Profit
GrossProfit
148451000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38947000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44443000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
127609000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
117024000
CY2020Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
20304000
CY2019Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
17278000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
64148000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
48277000
CY2019Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1500000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
3745000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
59251000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
63221000
us-gaap Operating Expenses
OperatingExpenses
191757000
us-gaap Operating Expenses
OperatingExpenses
169046000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12352000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12415000
us-gaap Operating Income Loss
OperatingIncomeLoss
-112161000
us-gaap Operating Income Loss
OperatingIncomeLoss
-20595000
CY2020Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
595000
CY2019Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
780000
us-gaap Interest And Other Income
InterestAndOtherIncome
1881000
CY2020Q3 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
852000
CY2019Q3 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-656000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
342000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-508000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4285000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-904000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6262000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-181000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16637000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13319000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-118423000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20776000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-889000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
187000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8723000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
381000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15748000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-13506000
us-gaap Net Income Loss
NetIncomeLoss
-109700000
us-gaap Net Income Loss
NetIncomeLoss
-21157000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.48
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.58
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44706000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36831000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44302000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36507000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15748000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-13506000
us-gaap Net Income Loss
NetIncomeLoss
-109700000
us-gaap Net Income Loss
NetIncomeLoss
-21157000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-423000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
530000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
141000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
364000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-170000
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
74000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
403000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
735000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-593000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
604000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
544000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1099000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16341000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12902000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-109156000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20058000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
673272000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4220000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17176000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
689000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-54058000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
641299000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1634000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13062000
CY2020Q2 gkos Convertible Debt Transaction Costs Amount
ConvertibleDebtTransactionCostsAmount
3267000
CY2020Q2 gkos Convertible Debt Taxes Amount
ConvertibleDebtTaxesAmount
12891000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
81554000
CY2020Q2 gkos Adjustments To Additional Paid In Capital Capped Call Transactions
AdjustmentsToAdditionalPaidInCapitalCappedCallTransactions
-35679000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
448000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-39894000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
662424000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5821000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9659000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-593000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-15748000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
661563000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
173860000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5406000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7129000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
436000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-1342000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
185489000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
319000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8247000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-6309000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
187805000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
6666000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8547000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
604000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-13506000
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
190116000
us-gaap Profit Loss
ProfitLoss
-109700000
us-gaap Profit Loss
ProfitLoss
-21157000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21981000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2674000
gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
3836000
gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
2405000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3234000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-9340000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-287000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-26000
us-gaap Share Based Compensation
ShareBasedCompensation
37733000
us-gaap Share Based Compensation
ShareBasedCompensation
23923000
gkos Stock Option Plan Expenses
StockOptionPlanExpenses
-3172000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-22000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-469000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
229000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
-298000
gkos Deferred Rent And Other Liabilities Adjustment
DeferredRentAndOtherLiabilitiesAdjustment
3343000
gkos Deferred Rent And Other Liabilities Adjustment
DeferredRentAndOtherLiabilitiesAdjustment
3666000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5629000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5828000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-22578000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-414000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-4329000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-2326000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6141000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-60000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-218000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
86000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33592000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3822000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
273798000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
63556000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
78084000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
61870000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4790000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3530000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-201601000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6386000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
287500000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
-9614000
gkos Payment For Capped Call Transactions
PaymentForCappedCallTransactions
35679000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10258000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14005000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4025000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
3388000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2607000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5002000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
253883000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12391000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-126000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-8000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18564000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9819000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71756000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38596000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90320000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48415000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
418000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
96000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions. Management considers many factors in selecting appropriate financial accounting policies and controls and in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the accompanying condensed consolidated financial statements relate to revenue recognition, the fair value of the liability component of the Convertible Notes, the incremental borrowing rate related to the Company’s leased assets, stock-based compensation expense and the valuation of certain intangible assets related to the Company’s acquisition of Avedro. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, this process may result in actual results differing materially from those estimated amounts used in the preparation of the condensed consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="color:#212529;">In </span>March 2020, the World Health Organization declared the outbreak caused by the novel strain of coronavirus (COVID-19) to be a global pandemic. While COVID-19 continues to evolve daily and its ultimate outcome is uncertain, it has caused significant disruption to individuals, governments, businesses, and financial markets. The Company’s condensed consolidated financial statements as of and for the three and nine months ended September 30, 2020 reflect the Company’s estimates of the impact of the COVID-19 outbreak. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company’s business, results of operations and financial condition, including sales, expenses, reserves and allowances, manufacturing, clinical trials, research and development costs and employee-related amounts, will depend on future developments that are uncertain, including the duration and severity of the COVID-19 outbreak, any future surges in the COVID-19 outbreak, and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. As a result, there may be changes to the Company’s estimates regarding the impact of COVID-19 in future periods.</p>
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80994000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62430000
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
9326000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
9326000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90320000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71756000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1400000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1200000
us-gaap Inventory Write Down
InventoryWriteDown
4300000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5023000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3835000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5092000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4005000
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
306646000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
847000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
52000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
307441000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
111161000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
409000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
17000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
111553000
CY2020Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
34267000
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
39657000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1382000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1240000
CY2020Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
32885000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
38417000
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6305000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
32108000
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
4316000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3884000
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
9269000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6586000
CY2020Q3 us-gaap Inventory Gross
InventoryGross
19890000
CY2019Q4 us-gaap Inventory Gross
InventoryGross
42578000
CY2020Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
9655000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
13525000
CY2020Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3693000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2784000
CY2020Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
3406000
CY2019Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1133000
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2394000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20771000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
34477000
CY2020Q3 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
39919000
CY2019Q4 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
51919000
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
321985000
CY2020Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
4530000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
118795000
CY2019Q4 gkos Cash Settled Stock Options Liability Fair Value Disclosure
CashSettledStockOptionsLiabilityFairValueDisclosure
6685000
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
10354000
CY2019Q3 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2020Q3 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
gkos Lessee Operating Lease Period For Lease Termination
LesseeOperatingLeasePeriodForLeaseTermination
P1Y
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
577000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2700000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3245000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2230000
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
3156000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2023000
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
5184000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2050000
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
5340000
CY2020Q3 gkos Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
2110000
CY2020Q3 gkos Finance Lease Liability Payments Due Year Six
FinanceLeaseLiabilityPaymentsDueYearSix
5500000
CY2020Q3 gkos Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
18521000
CY2020Q3 gkos Finance Lease Liability Payments Due After Year Six
FinanceLeaseLiabilityPaymentsDueAfterYearSix
107522000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33456000
CY2020Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
126702000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13207000
CY2020Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
66000000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
20249000
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
60702000
CY2020Q3 gkos Lessee Operating Lease Option To Extend Value
LesseeOperatingLeaseOptionToExtendValue
11900000
CY2020Q3 gkos Lessee Financing Lease Option To Extend Value
LesseeFinancingLeaseOptionToExtendValue
75800000
us-gaap Lessee Operating Lease Lease Not Yet Commenced Existence Of Option To Extend
LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfOptionToExtend
true
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64831000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58509000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151725000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
171135000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64831000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58509000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151725000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
171135000
gkos Period For Payment On Invoice Terms
PeriodForPaymentOnInvoiceTerms
P30D
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21279000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
245021000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2595000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
263705000
CY2020Q3 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21279000
CY2020Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
430055000
CY2019Q4 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2595000
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
448739000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6228000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
24912000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24912000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24912000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
24619000
CY2020Q3 gkos Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
139438000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
245021000
gkos Share Based Compensation Number Of Plans
ShareBasedCompensationNumberOfPlans
4
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
gkos Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Percentage On First Anniversary Date Of Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPercentageOnFirstAnniversaryDateOfGrant
0.25
gkos Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod
P3Y
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
54800000
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.053
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
19200000
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13800000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9659000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8547000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34561000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23923000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.074
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8700000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
CY2020Q1 gkos Coronavirus Aid Relief And Economic Security Act Carryback Net Operating Losses Period
CoronavirusAidReliefAndEconomicSecurityActCarrybackNetOperatingLossesPeriod
P5Y
gkos Income Tax Expense Benefit From Coronavirus Aid Relief And Economic Security Act
IncomeTaxExpenseBenefitFromCoronavirusAidReliefAndEconomicSecurityAct
-400000
CY2020Q3 gkos Income Tax Expense Benefit From Coronavirus Aid Relief And Economic Security Act
IncomeTaxExpenseBenefitFromCoronavirusAidReliefAndEconomicSecurityAct
-400000
CY2020Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
8800000
CY2020Q3 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2019Q4 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2020Q3 gkos Number Of Months Of Lease Term For Adjustments Of Letters Of Credit Balance Outstanding To Begin
NumberOfMonthsOfLeaseTermForAdjustmentsOfLettersOfCreditBalanceOutstandingToBegin
37
gkos Frequency Of Adjustments Of Letters Of Credit Balance Outstanding
FrequencyOfAdjustmentsOfLettersOfCreditBalanceOutstanding
P12M
gkos Adjustment Percentage Of Letters Of Credit Balance Outstanding
AdjustmentPercentageOfLettersOfCreditBalanceOutstanding
0.20
CY2020Q3 gkos Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments
MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments
2000000.0
CY2020Q3 gkos Number Of Other Irrevocable Letters Of Credit Outstanding
NumberOfOtherIrrevocableLettersOfCreditOutstanding
2
CY2020Q3 gkos Restricted Cash Pledged For Office Lease Agreement
RestrictedCashPledgedForOfficeLeaseAgreement
400000
CY2020Q3 gkos Restricted Cash Pledged For Credit Card Program
RestrictedCashPledgedForCreditCardProgram
200000
CY2020Q3 gkos Restructuring Headcount Reduction Number
RestructuringHeadcountReductionNumber
40
us-gaap Restructuring Charges
RestructuringCharges
1100000
us-gaap Payments For Restructuring
PaymentsForRestructuring
4900000
CY2020Q3 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
5300000
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
4096000
us-gaap Restructuring Charges
RestructuringCharges
1131000
us-gaap Payments For Restructuring
PaymentsForRestructuring
4921000
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
306000
CY2020Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4500000
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
3700000
CY2020Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
4600000
CY2019Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
3500000
CY2020Q3 gkos Other Commitment Obligation Amount
OtherCommitmentObligationAmount
3800000
gkos Number Of Business Activities
NumberOfBusinessActivities
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001558370-20-012925-index-headers.html Edgar Link pending
0001558370-20-012925-index.html Edgar Link pending
0001558370-20-012925.txt Edgar Link pending
0001558370-20-012925-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gkos-20200930.xsd Edgar Link pending
gkos-20200930x10q.htm Edgar Link pending
gkos-20200930x10q_htm.xml Edgar Link completed
gkos-20200930xex31d1.htm Edgar Link pending
gkos-20200930xex31d2.htm Edgar Link pending
gkos-20200930xex32d1.htm Edgar Link pending
gkos-20200930xex32d2.htm Edgar Link pending
gkos-20200930_cal.xml Edgar Link unprocessable
gkos-20200930_def.xml Edgar Link unprocessable
gkos-20200930_lab.xml Edgar Link unprocessable
gkos-20200930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending